Krystal Biotech Reports First Quarter 2020 Financial Results And Provides Update On Operational Progress

KB105 interim Phase 1/2 clinical data for treatment of autosomal recessive congenital ichthyosis (ARCI) to be announced at the Society for Investigative…


more on globenewswire.com